chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started having heart pvc and pac second day after first shot. Then on april 11 went in to er for chect pain turned out to be panic attack. On april 12 developed bumps on left front shoulder. On april 18 read article about vaccine causing shingles. Went to er and they confirmed shingles. At this time still have shingles on front and back left shoulder.
pt brought to ED with poor oral intake, pain with coughing  after recent cholecystitis with percutaneous biliary drain; pt had a positive COVID test 5 days earlier; still positive for COVID in ED; admitted to ICU; given decadron; respiratory status decreased; noninvasive ventilator for respiratory failure; DNR/DNI; pt worsened with an increased need for vasopressors; went into A Fib with RVR and passed away in the hospital
This spontaneous report was received from a nurse practitioner refers to a patient of unknown age and gender. Medical history was not reported. The nurse practitioner informed that on 28-AUG-2014 the patient was vaccinated with PROQUAD injection, 0.5 ml, subcutaneous, which expired on 22-AUG-2014 (lot number were not reported). No adverse effects were reported. The outcome of the event was unknown.  Follow up information received with updates on 28-OCT-2014, regarding 5 year old male patient with know demographics. It was reported that on 25-AUG-2014 at 11:30 PM, the patient was vaccinated with second dose of PROQUAD injection, lot # J002306. expire date 22-AUG-2014 to the left arm. No adverse effects were reported. This is one of the several report received from the same reporter. Additional information has been requested.
Pt vax w/ 3 hepta B; testing 2 months after 3rd dose indicated titer neg.   After 2 boosters titer still neg.
The nurse that gave the vaccine diluted the vial with 0.25ml of sterile dilutant and then drew up 0.25ml and administered the vaccine. Patient did not have any adverse reactions, notified mom of the mistake.  Per the recommendations of Moderna when called, we are going to repeat the vaccine at his next office visit.
she was sick for about 8 hours; Throwing up; Unable to keep anything down; Headache; Chills; Ringing in the ears; Hot flashes; Blood pressure went up; Was so dizzy if she moved her eyes she would nearly pass out; Was so dizzy if she moved her eyes she would nearly pass out; Very weak and tired; Very weak and tired; not feeling well; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID VACCINE; lot number: EL3247; expiration date: unknown) at vaccination age of 69-year-old via an unspecified route of administration left arm on 28Jan2021 10:00 at a single dose for To keep from getting COVID (covid-19 immunization). The patient medical history was none. The patient's concomitant medications were not reported. The patient stated that she got the first vaccine the other day and within 12 hours (28Jan2021 22:00), she was not feeling well. At 8:30 the next morning (29Jan2021), she was sick for about 8 hours. She was throwing up, had a headache, chills, ringing in the ears, hot flashes, her blood pressure went up, she was unable to get anything down, not even medication [pending clarification]. She was so dizzy if she moved her eyes, she would nearly pass out. She could not move out of the chair for about 6-8 hours. The dizziness was severe and awful. She added only one ear is ringing really bad, the right ear. It is off and on and persisting. Her very weak and tired which was persistent. One hour it may be bad and the next she will be drained. The patient inquired if it is true since she heard the second dose is worse. She also wants to know if she should get the second dose or not. The received treatment for the adverse events was reported as none [pending clarification]. The patient underwent lab tests and procedures which included blood pressure (blood pressure measurement) was reported that her blood pressure went up and recovered on 29Jan2021, and weight was 175-180 pounds on an unspecified date. The outcome of the event feeling unwell was unknown, as for the events weakness, tiredness and ringing in ears were not recovered, while the outcome of the other events was recovered on 29Jan2021.  Information about Lot/Batch number has been requested.
pt noticed rapid HR (170) and took a verapamil. It came down to normal in a half hour
This spontaneous report was received from a female patient of unknown age reporting on herself. On 08-NOV-2014 the patient was vaccinated with ZOSTAVAX (dose, route of administration and lot # were not reported). In November 2014 the patient experienced swelling, lump, itchiness, redness and warmth at the injection site. The patient sought medical attention (she called her pharmacist) and received TYLENOL as treatment for the adverse events. The outcome of the events was unknown. Additional information has been requested.
The injection site swollen with significant pain, and developed skin rash on the backside of both upper arms (no itch or any other feeling  of those rashes).
Right leg paresthesia and slight left leg paresthesia; tingling mainly in the right foot and calf; Itching mainly in the right foot and calf; Slight burning sensation mainly in the right foot and calf; Most recent COVID-19 vaccine was administered 17 days after first dose of COVID-19 vaccine; This is a spontaneous report from a contactable physician (patient). A 31-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK9231), intramuscular in left arm, on 04Jan2021 at 15:00, at a single dose, for COVID-19 immunization. The patient's medical history included gastritis. There were no concomitant medications. The patient previously took the first dose of BNT162B2 on 18Dec2020 at 2:30 PM for COVID-19 immunization (intramuscular in left arm; Lot Number: EL0140). The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Jan2021 at 3 PM, the most recent COVID-19 vaccine was administered in a hospital, 17 days after first dose of COVID-19 vaccine. On 04Jan2021 at 10 PM, the patient experienced right leg paresthesia and slight left leg paresthesia; and tingling, itching, and slight burning sensation mainly in the right foot and calf. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown.
pt stated after getting the vax he woke about 1 AM feverish, sweating, severe headache, his body was shaking and his teeth chattering.  He put a blanket over him to break fever.  His teeth were chattering.  He took Tylenol and his temp it was 100.4.  These symptoms latest a couple of days.
Patient was given HEPATITIS B vaccine in office in his right deltoid. No complaints or concerns until about 30 minutes after immunization. He showed me his right arm and it had 5-6 welps posterior arm and one welps on his left upper arm. No difficulty breathing, swallowing, or shortness of breath noted. Vital signs: 124/84 HR:87 Pulse Ox: 97% on room air  Resp:18 No pain Temp: 97.9 oral. Provider evaluated patient and administered benadryl 25mg oral and solumedrol 125mg IM. No complaints noted.
Nausea, migraine, Joint pain, body aches, weakness, blurry vision.  Tylenol was taken. Zero relief.  Excedrin was taken for the migraine. Zero relief.
Information was received on 09-MAY-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. On 21-MAR-2015, the patient received a dose of ZOSTAVAX vaccine for it's intended purpose: the prevention of shingles. Shortly thereafter, the patient noticed a rash on her right buttock and right labia and experienced mild pain and burning, aches, fever and fatigue. On or about 28-MAR-2015, the patient presented to her physician for these complaints and was diagnosed with herpes zoster.  The patient's physician diagnosed her complaints as being related to receiving the ZOSTAVAX vaccine. The patient subsequently suffered from recurring itchy, burning bumps on her legs and ankles, sporadic nerve pain in the area where she had the rash. The patient was eventually diagnosed with postherpetic neuralgia. As a direct and proximate result of the defective ZOSTAVAX vaccine, the patient's symptoms have resulted in physical limitations not present prior to using ZOSTAVAX. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result, the patient sustained severe and permanent injuries. Further as a tragic consequence, the patient suffered serious, progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. She has incurred and will continue to incur medical expenses and other economic harm as a direct result of use of ZOSTAVAX. Herpes zoster and post herpetic neuralgia were considered disabling. Additional information has been requested.
Syncopal episode lasting 5-10 seconds 3 minutes after vaccinations. Wavering consciousness for 8 minutes after waking up until EMS arrived. Hypotensive from EMS vitals. Sinus bradycardia on ECG in ER. Persistent orthostatic hypotension despite 1800 mL NS bolus led to peds admission. Diagnosis of vasovagal syncope.
Pt arrived  #1 via wheelchair with c/o feeling "different" with inability to elaborate on specific symptoms. Pt able to state she felt mildly lightheaded, but not dizzy upon further investigation. Denies N/V. No diaphoresis noted. Ambulatory independently. VSS. No s/s of distress noted. Provided snack and water. Pt reported improvement. Discharged to home. Declined wheelchair. Escorted to exit with staff. VS are as follows: 0921: BP 170/86, HR 70, RR 18, O2 sat 98% on RA 0926: BP 161/88, HR 67, RR 18, O2 at 97% on RA
I was diagnosed with Bell's Palsy and have had severe and persistent symptoms to the point that I can no longer do my full time job as a teacher. I am now forced to apply for disability retirement after teacher for 24 years.
pt recv vax 23OCT97 11AM & had a fever of 102.6 @ 2PM 23OCt;gave APAP;felt warm before bed gave child motrin 9PM 23OCT;woke up @ 5AM 24OCT burning up;didn't take temp was having sz like startles;sl fever rest of day;26OCT woke up w/spots
Information has been received from a medical assistant referring to unspecified amount of patients of unknown age and gender. The patients' medical history, concomitant therapy and drug reactions were not reported. On 26-OCT-2016, the patients were vaccinated with improperly stored doses of VAQTA (lot # M022924 with expiration date 24-JAN-2018, lot # M003618 with expiration date 18-NOV-2017, lot # reported as M031806 with expiration date 30-03-2018, lot # 022924 with expiration date 24-JAN-2018, lot # reported as M027879 with expiration date 24-JAN-2018; dose and route were not provided), which were exposed to 49.1 Fahrenheit (F) for 55 minutes. No adverse effects were reported. The data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Within 1 hr of receiving shot felt heaviness and pain in lungs, gradually getting worse then swollen face and clearing of throat constantly by hr 4.  By hr 7 gradual lung pain and face swelling reduced.  Today 12/29 still have some lung pain little face swelling but still have trouble breathing while walking and talking.
Information was received on 06-MAR-2017 from a medical assistant via a company representative regarding unspecified patients. Medical history, concurrent conditions and concomitant medications were not reported. On unspecified dates, unspecified patients were administered improperly stored GARDASIL (lot # M036059, expiration date 03-JUN-2019) and ROTATEQ (lot # M038846, expiration date 26-APR-2018). Temperature : 0 degrees Celsius to 2 degrees Celsius for 2 hours and 30 minutes; also >8 degrees Celsius but < 25 degrees Celsius for 45 minutes. There was no previous temperature excursion. No adverse effects were reported. Additional information is not expected.
Received Varicella vaccine left arm Subq. Before 12 noon on 3-17-07. At bed time- red area as big as a quarter. The next AM 3/18/07-4"x6" area red, hard, hot, swollen, painful and itching. 3-21-07-still red and painful and itching-but getting better.
This spontaneous report was received from a licensed practical nurse and refers to a 4 month old patient of unknown gender (date of birth 14-MAY-2017). The patient's concurrent conditions and medical history were not reported. On 12-OCT-2017, the patient was vaccinated with a first dose of ROTATEQ orally, lot # N004816, expiration date 12-OCT-2018 (dose and frequency were not reported) for prophylaxis (inappropriate schedule of drug administration). No adverse effects were reported.
Patient said about a week after the vaccine he began to experience pain just on his left side and reported a rash on his leg too. Patient is still experiencing loss of sensation to some of his fingers on the left side and nerve pain moving his arm. It has been about same level of pain since it first started. Patient said his doctor is going to do an MRI. Patient is not taking any medications for the symptoms.
This spontaneous report as received from a medical assistant refers to a 14 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 13-JUN-2014 the patient was vaccinated with first dose of GARDASIL (dose, frequency and route of administration were not reported) (lot # J013324, expiry date: 12-FEB-2016) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for GARDASIL. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, 1407USA012905, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012657, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012986, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA013014 (same reporter link). Additional information has been requested.
Rapid Atrial Fibrillation occured 12 hours after first injection of Pfizer vaccine.  I had no prior history of any cardiac events.
Hives; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2023SA104066 (Sanofi).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: URTICARIA (non-serious), outcome "unknown", described as "Hives".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient received first pfizer dose at 1040 AM. At 1050 the patient complained of breathing issues. Patient called mom who was in car and she brought in her epipen. She also called 911 from the car. Patient kept saying no to the EpiPen but when he said he was throat was getting worse, pharmacist administered the dose. Paramedics arrived within minutes and assisted the patient. Breathing was better and patient was taken to local hospital
Numb left ear and parts of left side of face; Heart Pressure; Irregular heart palpitations; very scary; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 51-year-old female patient received first dose of BNT162B2 (Lot Number: ER8731) via an unspecified route of administration, administered in left arm on 07Apr2021 at 14:00 at age of 51-year-old as single dose, and received second dose of BNT162B2 (Lot Number: EWO167) via an unspecified route of administration, administered in left arm on 28Apr2021 at 14:00 at age of 51-year-old as single dose for covid-19 immunisation. Medical history was not reported. Facility where the most recent COVID-19 vaccine was administered reported as Public Health Clinic facility. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. No any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 28Apr2021 at 16: 00, patient experienced heart pressure, irregular heart palpitations - almost went to emergency room a few times. Patient was very scary, had numb left ear and parts of left side of face. No Hospitalization Prolonged. No treatments were received for events heart pressure, very scary and numb left ear and parts of left side of face. The outcome of events was recovered with sequelae.  Information on Lot/Batch number was available. Additional information has been requested.
Information has been received from a physician concerning a 66 year old female patient with codeine allergy, hypertension and hypothyroidism who 2 months ago, in approximately October 2008, at a different facility, was vaccinated with a dose of ZOSTAVAX (Oka/Merck) 0.5 mL SQ. There was no concomitant medication. One week after the vaccination, in approximately October 2008, the patient developed injection site reaction. The patient had been having pain, redness and swelling at the injection site. The patient's injection site reaction persisted. The patient sought medical attention, she saw the physician. Additional information has been requested.
14 cm x 17 cm area of redness/swelling/warmth to (L) thigh around injection site. 5cm x 8cm area of redness/swelling/warmth to (R) thigh around injection site.
Patient was due for meningococcal A, C, W, Y - NOT meningococcal B.   Meningococcal B was grabbed and administered to the patient.  Monitored patient x 30 minutes. No s/s of adverse reactions.
Information has been received from a nurse practitioner concerning a female teenager who in 2007 was vaccinated with the first dose of GARDASIL and an unspecified dates was vaccinated with the second and the third dose of GARDASIL. Concomitant therapy included therapy unspecified. Following the second dose of GARDASIL the patient developed a small lighter skin discoloration at the injection site. The patient sought medical attention, office visit. At the time of the reporting, the patient was recovering. The reporter also indicated the patient's twin sister had the same symptoms after receiving the second dose of GARDASIL. Additional information is not expected.
GOT THE SHOT ON MARCH 2ND.  ARM WAS SORE AND TENDER FOR ABOUT A WEEK FELT TIRED.   THE NEXT WEEK MY ARM WAS FINE.  ON SUNDAY MARCH 14TH I NOTICED A RASH AND IT WAS INFLAMMED.  REPORTED TO MY PRIMARY DOCTOR TODAY.  GOING TO URGENT CARE TODAY.
Pt called complaining of swollen arm (size of "tennis ball" and feeling of warmth underneath the injection site (no reaction at injection site) the day after vaccination which was 6/16/23. Pt said she has been taking extra strength Tylenol for discomfort, and that swelling is slightly better than Saturday but still feels warm.
Patient woke up and had visual trouble. It was hard to focus. I sat up and was very dizzy. I had to walk slowly due to extreme vertigo. I had trouble walking down stairs. The vertigo was severe and lasted approximately 5 hrs. It has since resolved. The visual disturbances are also resolved. I have been receiving the Flu vaccine for over 20 years and I have never had a reaction. I am attributing the incident of vertigo and visual disturbances the morning after the vaccine to a reaction. I have no other symptoms. I didn't f/up with a Dr since the sxs have resolved. It was a scary reaction. I am a RN and thought that I should notify VAERS of the incident. Please feel free to contact me for any additional information.
patient given expired vaccine; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient given expired vaccine) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030H21B) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: pfizer vaccine (Dose-2) and pfizer vaccine (Dose-1). Past adverse reactions to the above products included No adverse event with pfizer vaccine and pfizer vaccine.    On 25-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 25-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient given expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient given expired vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 07-APR-2016 the patient was vaccinated with an improperly stored dose of GARDASIL single-dose vial (SDV) (lot # L010596, expiration date 06-APR-2017; dose and route were not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for each time were 840, 34, and R; 168, 32 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Severe right arm pain, followed by pain spreading from right axilla across right anterior chest wall and finally to left chest wall, with an increase of pain with chest expansion from respirations.
No additional adverse events reported.; an expired dose of PNEUMOV AX 23 was administered today/expired vaccine administered; This spontaneous report was received from a nurse, referring to a 72-year-old female patient. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions and concomitant medications were not reported.  On 13-OCT-2021, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml, lot # T021329 was confirmed to be valid, expiry date 03-OCT-2021 (route of administration, vaccination site were not specified) for prophylaxis. No additional adverse effect was reported.